下载App
扫码立即下载
  • 下载App

    扫码立即下载

  • 在线客服

    登录后咨询在线客服
+
恭喜您!
成功领取价值超 5000港元/年的高级行情
前往体验 >>

Pure Extracts Signs White Label Agreement with West Coast Licensed Producer
纯萃取物与西海岸特许生产商签署白标协议

GlobeNewswire ·  {{timeTz}}

VANCOUVER, British Columbia, Jan. 12, 2022 (GLOBE NEWSWIRE) -- Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) ("Pure Extracts" or the "Company"), a plant-based extraction company focused on cannabis, hemp, functional mushrooms and the rapidly emerging psychedelic sector, is pleased to announce that its wholly owned subsidiary, Pure Extracts Manufacturing Corp., has signed a custom manufacturing/white label agreement with a West Coast Licensed Producer to launch a line of vape products.

温哥华,不列颠哥伦比亚省,2022年1月12日(环球通讯社)纯萃取技术公司。纳斯达克股票代码:PRXTF)(场外交易代码:PRXTF)(XFRA:A2QJAJ)(以下简称“纯提取物”或“公司”)是一家专注于大麻、大麻、功能性蘑菇和迅速崛起的迷幻领域的植物性提取物公司,该公司高兴地宣布,其全资子公司Pure Extracts Manufacturing Corp.与西海岸一家特许生产商签署了定制制造/白标协议,将推出一系列蒸气产品。

The agreement calls for the extraction of premium cannabis supplied by the LP and the subsequent formulation into high quality, full-spectrum oil (FSO) 1 gram vape cartridges. These products will be created by collaboration between the two companies with a reliance on Pure Extracts' 30+ proprietary formulations and its optimized vape hardware. Pure Extracts will be providing co-manufacturing extraction services. The initial order has an approximate retail sales value of $525,000

该协议要求提取由LP供应的优质大麻,并将随后的配方制成高质量的1克全光谱油(FSO)蒸发弹。这些产品将由两家公司合作开发,依靠Pure Extracts的30+专利配方及其优化的VAPE硬件。Pure Extract将提供联合制造的提取服务。最初的订单零售额约为525,000美元。

This science-based LP has extensive experience in the growing medical-grade cannabis for patients and are now excited to apply their experience towards producing first-rate cannabis for the legalized adult-use market in Canada. Their meticulous standards are used at every step of product development, from growing and processing to R&D.

这家以科学为基础的有限合伙公司在不断增长的医用级大麻患者方面拥有丰富的经验,现在很高兴能将他们的经验应用于为加拿大合法的成人使用市场生产一流的大麻。从种植、加工到研发,产品开发的每一步都采用了他们的一丝不苟的标准。

Pure Extracts CEO, Ben Nikolaevsky, remarked, "We are excited about launching a white label product with our new customer, as they are focused on creating state-of-the-art products utilizing cannabis they grow themselves. With the addition of this customer and the increased capacity and flexibility our new cosolvent injection system provides, we have begun to execute our strategy with high quality producers and branding specialists to get their white label products into the provincial retailers and drive up to $3 million of annual revenue from this vertical."

Pure Extracts首席执行官Ben Nikolaevsky说:“我们很高兴能与我们的新客户一起推出白标产品,因为他们专注于利用他们自己种植的大麻创造最先进的产品。随着这一客户的增加,以及我们新的助溶剂注射系统提供的更大的容量和灵活性,我们已经开始与高质量的生产商和品牌专家一起执行我们的战略,将他们的白标产品推向省级零售商,并从这个垂直领域获得高达300万美元的年收入。”

ON BEHALF OF THE BOARD
"Ben Nikolaevsky"
Ben Nikolaevsky
CEO and Director

我代表董事会
"本·尼古拉耶夫斯基"
本·尼古拉耶夫斯基
首席执行官兼董事

About Pure Extracts (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ)

关于纯提取物(CSE:Pull)(场外交易:PRXTF)(XFRA:A2QJAJ)

Pure Extracts Technology Corp. features an all-new, state-of-the-art processing facility located just 20 minutes north of world-famous Whistler, British Columbia. The bespoke facility has been constructed to European Union GMP standards aiming towards export sales of products and formulations, including those currently restricted in Canada, into European jurisdictions where they are legally available. Pure Extracts was granted its Standard Processing License by Health Canada under the Cannabis Act on September 25, 2020, and its Sales Amendment on July 19, 2021. The Company's stock began trading on the Canadian Securities Exchange (CSE) on November 5, 2020.

Pure Extracts Technology Corp.拥有一个全新的、最先进的加工设施,位于世界著名的不列颠哥伦比亚省惠斯勒以北仅20分钟车程。这个定制设施是按照欧盟GMP标准建造的,旨在将产品和配方(包括目前在加拿大受到限制的产品和配方)出口到合法可获得的欧洲司法管辖区。根据2020年9月25日的大麻法案和2021年7月19日的销售修正案,纯萃取物获得了加拿大卫生部颁发的标准加工许可证。该公司的股票于2020年11月5日在加拿大证券交易所(CSE)开始交易。

Find out more at

了解更多信息

Or contact:
Pure Extracts Investor Relations
Tel: +1 604 493 2052
info@pureextractscorp.com    

或联系方式:
纯提取投资者关系
电话:+16044932052
邮箱:info@pureExtract tcotp.com

This news release contains forward-looking statements relating to the future operations of Pure Extracts,
and the other statements are not historical facts. Forward-looking statements are often identified by terms such as "will", "may", "should", "anticipate", "expects" and similar expressions. All statements other than statements of historical fact, included in this release, including, without limitation, statements regarding the future plans and objectives of Pure Extracts', are forward-looking statements and involve risks and uncertainties. A number of factors could cause actual events, performance or results to differ materially from what is projected in forward looking statements. Although we believe that the assumptions underlying these statements are reasonable, they may prove to be incorrect, and we cannot assure that actual results will be consistent with these forward-looking statements. Given these risks, uncertainties and assumptions, investors should not place undue reliance on these forward-looking statements. Whether actual results, performance or achievements will conform to the Company's expectations and predictions is subject to a number of known and unknown risks, uncertainties, assumptions and other factors, including those listed under "Risk Factors" in the Company's Annual Information Form. The Company does not undertake to update any forward-looking information, except as, and to the extent required by, applicable securities laws.

本新闻稿含有与纯萃取物公司未来运营有关的前瞻性陈述。
其他的说法也不是历史事实。前瞻性陈述通常由诸如“将”、“可能”、“应该”、“预期”、“期望”和类似的表达方式来识别。本新闻稿中除历史事实陈述外的所有陈述,包括但不限于有关Pure Extract的未来计划和目标的陈述,均为前瞻性陈述,涉及风险和不确定因素。许多因素可能导致实际事件、业绩或结果与前瞻性陈述中预测的大不相同。尽管我们认为这些陈述背后的假设是合理的,但它们可能被证明是不正确的,我们不能保证实际结果与这些前瞻性陈述一致。鉴于这些风险、不确定性和假设,投资者不应过度依赖这些前瞻性陈述。无论实际结果、业绩或成就是否符合公司的预期和预测,都会受到许多已知和未知的风险、不确定性、假设和其他因素的影响,包括那些在公司年度信息表格中的“风险因素”中列出的因素。除非适用的证券法要求,否则公司不承诺更新任何前瞻性信息。

This news release contains information about potential sales revenue from supply agreements, which may be considered as disclosure of financial outlook under applicable securities laws. Such information is subject to the same assumptions, risk factors, limitations, and qualifications as set forth in the above paragraph. Specifically, estimated sales revenue which may be derived from supply contracts has been calculated based on current wholesale prices and assume, among other things, that the Company will be able to find buyers for its products. The financial outlook contained in this news release was made by management as of the date of this news release and was provided for the purpose of providing readers with an understanding of the potential revenue which may be derived from any agreements recently entered into by the Company, and are not an estimate of profitability or any other measure of financial performance. Readers are cautioned that the financial outlook contained in this document should not be used for purposes other than for which it is disclosed herein.

本新闻稿包含有关供应协议的潜在销售收入的信息,根据适用的证券法,这可能被视为财务前景的披露。此类信息受上段所述的相同假设、风险因素、限制和限制。具体地说,可能来自供应合同的估计销售收入是根据当前的批发价计算的,并假设该公司将能够为其产品找到买家。本新闻稿中包含的财务展望是由管理层在本新闻稿发布之日作出的,目的是让读者了解公司最近签订的任何协议可能带来的潜在收入,而不是对盈利能力的估计或任何其他财务业绩的衡量。提醒读者,本文件中包含的财务展望不应用于本文披露以外的其他目的。

The CSE has neither approved nor disapproved the contents of this press release.

CSE既没有批准也没有反对本新闻稿的内容。


本页的译文内容由软件翻译。富途将竭力但却不能保证翻译内容之准确和可靠,亦不会承担因任何不准确或遗漏而引起的任何损失或损害。

风险提示:以上内容仅作为作者或者嘉宾的观点,不代表富途的任何立场,不构成与富途相关的任何投资建议。在作出任何投资决定前,投资者应根据自身情况考虑投资产品相关的风险因素,并于需要时咨询专业投资顾问意见。富途竭力但不能证实上述内容的真实性、准确性和原创性,对此富途不做任何保证和承诺。

回到顶部